palmitoylethanolamide.com.au
HomeResearchDong-Soon 2021

GPR119 and GPR55 as Receptors for Fatty Acid Ethanolamides, Oleoylethanolamide and Palmitoylethanolamide

Dong-Soon Im. Int J Mol Sci. 2021 Jan 21;22(3):1034.

ReviewHumansOther animals

Design
Review
Subjects
Not stated in the abstract
Dose used in the study
Not stated in the abstract
Duration
Not stated in the abstract
What was measured
How oleoylethanolamide and palmitoylethanolamide act through PPAR-alpha, TRPV1, GPR119 and GPR55, and what that means for glucose balance, inflammation, anaphylaxis, pain and appetite.

What the authors reported

Oleoylethanolamide and palmitoylethanolamide are reported to affect glucose balance, inflammation, anaphylaxis, pain and appetite, acting through nuclear receptors, ion channels and membrane receptors including PPAR-alpha, TRPV1, GPR119 and GPR55. No study-level results or numbers are given.

Limits of this study

A narrative review with no numbers. The author declares no conflict of interest.

Source

PubMed 33494185 · doi:10.3390/ijms22031034

Entry checked against the abstract on PubMed on 2026-09-22. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.